Abstract
The unusual sugar 2,3-diacetamido-2,3-dideoxy-d-mannuronic acid, or ManNAc3NAcA1, has been observed in the lipopolysaccharides of both pathogenic and nonpathogenic Gram-negative bacteria. It is added to the lipopolysaccharides of these organisms by glycosyltransferases that use as substrates, UDP-ManNAc3NAcA. Five enzymes are ultimately required for the biosynthesis of UDP-ManNAc3NAcA starting from UDP-N-acetylglucosamine. The second enzyme in the pathway, encoded by the wlba gene and referred to as WlbA, catalyzes the NAD-dependent oxidation of the C-3' hydroxyl group of the UDP-linked sugar. Here we describe a combined structural and functional investigation of the WlbA enzymes from Bordetella pertussis and Chromobacterium violaceum. For this investigation, ternary structures were determined in the presence of NAD(H) and substrate to 2.13 Å and 1.5 Å resolution, respectively. Both of the enzymes display octameric quaternary structures with their active sites positioned far apart. The octamers can be envisioned as tetramers of dimers. Kinetic studies demonstrate that the reaction mechanisms for these enzymes are sequential and that they do not require α-ketoglutarate for activity. These results are in sharp contrast to those recently reported for the WlbA enzymes from Pseudomonas aeruginosa and Thermus thermophilus, which function via ping-pong mechanisms that involve α-ketoglutarate. Taken together the results reported here demonstrate that there are two distinct families of WlbA enzymes, which differ with respect to amino acid sequences, quaternary structures, active site architectures, and kinetic mechanisms.
The incidence of whooping cough has risen steadily in the last few years with several states, including Ohio and California, witnessing their largest outbreaks in 25 and 60 years, respectively. Whereas the disease is often mild in adults, it can result in significant morbidity and mortality rates in children under the age of two. The causative agent of whooping cough is Bordetella pertussis, a Gram-negative bacterium that infects humans by colonizing lung epithelial cells. As observed in most other Gram-negative bacteria, B. pertussis has a lipopolysaccharide or LPS, which serves as the major structural component for its outer membrane. The LPS is composed of lipid A, the core polysaccharide, and the O-antigen. A rather rare diacetylated sugar, 2,3-diacetamido-2,3-dideoxy-d-mannuronic acid or ManNAc3NAcA, is found in the O-antigen of B. pertussis, and it has also been observed in the LPS of Pseudomonas aeruginosa serogroup O2 (1). The physiological importance of the O-antigen in B. pertussis is underscored by the fact that it confers resistance to complement-mediated cell lysis (2), and it also prevents clearance of the bacterium by the pulmonary surfactant protein A (3).
Five enzymes are required for the production of UDP-ManNAc3NAcA in both B. pertussis and P. aeruginosa as indicated in Scheme 1 (4–6). The focus of this investigation is on the enzyme WlbA, which catalyzes the second step in the pathway, namely the oxidation of UDP-N-acetyl-d-glucosaminuronic acid (UDP-GlcNAcA) to UDP-2-acetamido-2-deoxy-3-oxo-d-glucuronic acid (UDP-3-keto-GlcNAcA). The enzyme is NAD-dependent, and a previous biochemical study of the protein from P. aeruginosa PAO1 demonstrated that it employs α-ketoglutarate to regenerate the oxidized cofactor necessary for the next round of catalysis (6). Indeed, α-ketoglutarate is absolutely required for catalysis by the P. aeruginosa enzyme (6). We recently reported the three-dimensional structures of WlbA from both P. aeruginosa and Thermus thermophilus in complex with NAD(H), with NAD(H) and α-ketoglutarate, and with NAD(H) and UDP-GlcNAcA. The enzymes from both bacterial species assumed unusual tetrameric quaternary structures with the NAD(H) moieties closely situated to one another as can be seen in Figure 1 (7). The individual subunits of the tetramers displayed overall folds similar to that reported for glucose-fructose oxidoreductase from Zymomonas mobilis (8). Strikingly, the UDP-linked substrates adopted highly unusual curved conformations in the active site clefts of the tetramers. In addition to the structural studies, we showed that these two enzymes catalyzed their reactions via ping-pong mechanisms (7).
Given that the WlbA enzymes from P. pseudomonas and B. pertussis catalyze the same reactions in the biosynthesis of UDP-ManNAc3NAcA (4), we anticipated that the structure of the B. pertussis enzyme would adopt a similar molecular architecture to that shown in Figure 1. We also assumed that the B. pertussis WlbA would use α-ketoglutarate to regenerate the oxidized cofactor. To our surprise, all attempts to solve the structure of the B. pertussis enzyme in the presence of α-ketoglutarate failed. Likewise, we were never able to demonstrate the recycling mechanism with the B. pertussis enzyme in vitro.
Here we report the structure of the B. pertussis enzyme in complex with NAD(H) and its UDP-linked substrate. Additionally, we describe the structure of WlbA from Chromobacterium violaceum, a Gram-negative bacterium that produces the antibiotic violacein (9). The B. pertussis and C. violaceum enzymes share an identity of 73% and a similarity of 86%. Details concerning the kinetic and structural data are presented.
Materials and Methods
Cloning, Expression, and Purification
Genomic DNA samples from B. pertussis (ATCC BAA-589) and C. violaceum (ATCC 12472) were obtained from the American Type Culture Collection. The first dehydrogenase cloned for this study was that from B. pertussis. Using PrimeSTAR HS DNA Polymerase (Takara BIO USA, Clontech Laboratories), the wlbA gene was PCR-amplified such that the forward primer 5'-AAAACATATGAGCTCACTTCCCATCACCGATCGAAAAATCCG and the reverse primer 5'-AAAACTCGAGTCAGTCCAGCGGCAGGGGGATGCGCACGC added NdeI and XhoI cloning sites, respectively. The gene encoding the dehydrogenase from C. violaceum was PCR-amplified such that the forward primer 5'-AAAACATATGATAGTGATTCCTCCGATTACCGATCGCAAGATCCG and the reverse primer 5'-AAACTCGAGTTAGTAATCCAGCGGCAGGCTGACGCGGCGGCC also added NdeI and XhoI cloning sites. Both purified PCR products were A-tailed and ligated into pGEM-T (Promega) vectors for screening and sequencing. The WlbA-pGEM-T vector constructs of the correct sequence were then appropriately digested and ligated into pET28JT vectors for protein production with a TEV protease cleavable N-terminal His6-tag (10).
For production of the dehydrogenase from B. pertussis, the WlbA-pET28JT plasmid was used to transform Escherichia coli Rosetta(DE3) cells (Novagen). The culture was grown at 37°C in LB media with shaking until the measured optical density at 600 nm was approximately 0.8, at which time the cell cultures were induced with 1.0 mM IPTG and then allowed to express protein at 21°C for 18 hours. WlbA was purified by standard procedures using NiNTA column chromatography at room temperature (with the lysis buffer containing 10% glycerol, and all buffers containing 500 mM NaCl). Following purification, the protein was dialyzed against 10 mM Tris-HCl and 200 mM NaCl at pH 8.0 and then concentrated to 14 mg/mL on the basis of an extinction coefficient of 0.57 (mg/mL)−1cm−1. Analysis by analytical ultracentrifugation showed the oligomerization state of the protein to be octameric (University of Wisconsin - Madison Biophysics Instrumentation Facility, supported by the University of Wisconsin - Madison and grants from the NSF (BIR-9512577) and the NIH (S10 RR13790)).
For production of the dehydrogenase from C. violaceum, the WlbA-pET28JT plasmid was used to transform E. coli Rosetta(DE3) cells (Novagen). The culture was grown at 37°C in LB media with shaking until the measured optical density at 600 nm was approximately 0.8, at which time the cultures were induced with 1.0 mM IPTG and allowed to express protein at 21°C for 18 hours. WlbA was purified by standard procedures using NiNTA resin at room temperature (with the lysis buffer containing 10% glycerol). Following purification, TEV protease was added to the protein at a 50:1 protein:TEV ratio. The digestion was allowed to proceed overnight at room temperature, and subsequently the reaction mixture was dialyzed against 50 mM sodium phosphate (pH 8), 300 mM NaCl, and 20 mM imidazole. Cleaved protein was separated from the TEV protease and any undigested protein via NiNTA column chromatography. The cleaved protein was pooled and dialyzed against 10 mM Tris-HCl and 200 mM NaCl at pH 8.0 and then concentrated to 19 mg/mL on the basis of an extinction coefficient of 0.69 (mg/mL)−1cm−1. Analysis by analytical ultracentrifugation determined the oligomerization state of this protein to be octameric as well.
Structural Analysis of WlbA
Crystallization conditions were initially surveyed with either the holoprotein or the protein incubated with 10 mM UDP-GlcNAcA. The hanging drop method of vapor diffusion was used along with a sparse matrix screen developed in the laboratory. The UDP-GlcNAcA ligand was prepared as previously described (7). For the B. pertussis enzyme, X-ray diffraction quality crystals were ultimately obtained via vapor diffusion by mixing in a 1:1 ratio the protein incubated with 10 mM UDP-GlcNAcA and a precipitant solution composed of 14 – 18% monomethylether poly(ethylene glycol) 5000, 200 mM NaCl, and 100 mM HEPPS (pH 8.5). The crystals belonged to the space group P21 with unit cell dimensions of a =102.3 Å, b = 320.0 Å, c = 103.8 Å, and β = 119.1°. The asymmetric unit contained sixteen monomers or two octamers. The crystals were stabilized for cryo-cooling by transferring them to a solution containing 25% monomethylether poly(ethylene glycol) 5000, 400 mM NaCl, 10 mM UDP-GlcNAcA, 18% 1,2-ethanediol, and 100 mM HEPPS (pH 8.5).
For the C. violaceum enzyme, X-ray diffraction quality crystals were grown via hanging drop by mixing in a 1:1 ratio the protein incubated with 10 mM UDP-GlcNAcA and a precipitant solution containing 15 – 19% monomethylether poly(ethylene glycol) 5000, 200 mM LiCl, and 100 mM HEPPS (pH 8.0). These crystals belonged to the space group I422 with unit cell dimensions of a = b = 106.7 Å, c = 143.4 Å, and one monomer per asymmetric unit. The crystals were stabilized for cryo-cooling by transferring them to a solution containing 24% monomethylether poly(ethylene glycol) 5000, 300 mM NaCl, 200 mM LiCl, 20% 1,2-ethanediol, and 100 mM HEPPS (pH 8.0).
X-ray data sets from flash-cooled crystals were collected at the Structural Biology Center Beamline 19-BM (Advanced Photon Source, Argonne National Laboratory, Argonne, IL). The data sets were processed and scaled with HKL3000 (11). X-ray data collection statistics are presented in Table 1.
Table 1.
MAD Phasing Data (C. violaceum WlbA) |
C. violaceum WlbA |
B. pertussis WlbA |
|||
---|---|---|---|---|---|
Peak | Inflection | Remote | |||
resolution limits | 50.0-1.90 (1.93-1.90)b |
50-1.90 (1.93-1.90)b |
50.0-1.90 (1.93-1.90)b |
30.0-1.50 (1.53-1.50)b |
30.0-2.13 (2.17-2.13)b |
wavelength | 0.97918 | 0.97953 | 0.97150 | 0.97921 | 0.97921 |
number of independent reflections | 32809 (1606) | 32827 (1618) | 32805 (1612) | 63793 (2839) | 297970 (12098) |
completeness (%) | 99.7 (100.0) | 99.6 (100.0) | 99.9 (100.0) | 96.9 (87.1) | 92.7 (75.5) |
redundancy | 14.1 (13.8) | 14.1 (13.7) | 14.3 (14.0) | 9.0 (2.8) | 3.8 (2.3) |
avg I/avg σ(I) | 51.5 (7.8) | 52.0 (7.8) | 47.8 (6.5) | 47.4 (2.2) | 27.8 (3.9) |
Rsym (%)a | 10.4 (32.2) | 9.6 (29.9) | 10.5 (39.3) | 5.9 (28.3) | 6.1 (16.1) |
Rsym = (• | I - I̅ | / • I) × 100.
Statistics for the highest resolution bin.
An initial structure was determined using a selenomethionine-labeled version of the C. violaceum WlbA, which was prepared using standard methods and purified and crystallized in the same manner as that for the wild-type enzyme. Nine of the thirteen possible selenium atoms were located by SOLVE (12), yielding an overall figure-of-merit of 0.64 to 1.9 Å resolution. A preliminary model was constructed with the software package COOT (13). The structure was then used as a search model for molecular replacement with PHASER (14) against the X-ray data set collected from a crystal of the wild-type protein. Refinement of the model with REFMAC (15) led to a final overall R-factor of 20.3% for all measured X-ray data from 30 to 1.5 Å resolution. Relevant refinement statistics are given in Table 2.
Table 2.
C. violaceum WlbA | B. pertussis WlbA | |
---|---|---|
resolution limits (Å) | 30.0-1.50 | 30.0-2.13 |
aR-factor (overall)%/no. reflections | 20.3/63793 | 18.7/297970 |
R-factor (working)%/no. reflections | 20.1/60557 | 18.3/282933 |
R-factor (free)%/no. reflections | 23.6/3236 | 26.9/15037 |
number of protein atoms | 2713b | 42024c |
number of heteroatoms | 354d | 1961e |
average B values | ||
protein atoms (Å2) | 25.2 | 41.1 |
ligands (Å2) | 27.8 | 35.1 |
solvent (Å2) | 33.7 | 41.1 |
weighted RMS deviations from ideality | ||
bond lengths (Å) | 0.013 | 0.005 |
bond angles (°) | 2.27 | 2.30 |
general planes (Å) | 0.013 | 0.010 |
R-factor = (Σ | Fo - Fc | / Σ | Fo |) × 100 where Fo is the observed structure-factor amplitude and Fc is the calculated structure-factor amplitude.
These include multiple conformations for Arg 216, Asn 217, Ser 237, Val 240, and Arg 313.
These include multiple conformations for Arg 230 and His 280 in subunit B, and Arg 228 in subunit D, Val 224 in subunit H, and Leu 344 in subunit L.
Heteroatoms include one NAD(H), 1 UDP-GlcNAcA, 1 sodium ion, 1 chloride ion, and 268 waters.
Heteroatoms include sixteen NAD(H) molecules, sixteen UDP-GlcNAcA ligands, and 617 waters.
The structure of the B. pertussis enzyme was determined via molecular replacement with PHASER using as a search model the monomer of the C. violaceum enzyme in which all ligands and solvent molecules had been removed. Iterative rounds of refinement with REFMAC, sixteen-fold molecular averaging with the software package DM (16) and model building with COOT led to a final overall R-factor of 18.7% for all measured X-ray data from 30 to 2.13 Å resolution. Relevant refinement statistics are presented in Table 2.
Measurement of Enzymatic Activity
Enzymatic activities of both the B. pertussis and C. violaceum dehydrogenases were monitored spectrophotometrically by following the increase in absorbance at 340 nm due to the conversion of NAD+ to NADH. Reactions were monitored continuously with a Beckman DU 640B spectrophotometer, and enzyme activities calculated from the initial rates. For the C. violaceum enzyme, assay mixtures were 0.75 mL in volume and contained 0.5 mg/mL enzyme, 100 mM NaCl, and 50 mM HEPPS (pH 8.5). Initial velocity patterns were evaluated by measuring the initial rates at four concentrations of each substrate: 7.0, 1.06, 0.56, and 0.35 mM UDP-GlcNAcA and 7.5, 4.0, 0.56, and 0.27 mM NAD+. The reactions were run at 25°C and initiated by the addition of the enzyme. Equation 1 was used to fit the data with the program SigmaPlot8. Kinetic parameters are listed in Table 3.
(1) |
Table 3.
C. violaceum WlbA with UDP-GlcNAcA |
C. violaceum WlbA with WlbC and UDP-GlcNAcA |
C. violaceum WlbA with UDP-GlcA |
B. pertussis WlbA with UDP-GlcNAcA |
B. pertussis WlbA with WlbC and UDP-GlcNAcA |
B. pertussis WlbA with UDP-GlcA |
|
---|---|---|---|---|---|---|
WlbA concentration (µM) | 24.5 | 6.1 | 23.0 | 14.4 | 4.9 | 14.4 |
Km for the UDP-sugar (mM) | 1.10 ± 0.08 | 0.0056 ± 0.0008 | 0.20 ± 0.02 | 2.36 ± 0.35 | 0.015 ± 0.002 | 2.05 ± 0.21 |
Km NAD+ (mM) | 0.47 ± 0.07 | 0.089 ± 0.009 | 0.45 ± 0.06 | 0.97 ± 0.04 | 0.055 ± 0.007 | 0.95 ± 0.05 |
Vmax µM/min | 0.46 ± 0.02 | 0.28 ± 0.01 | 0.12 ± 0.01 | 4.09 ± 0.07 | 1.13 ± 0.04 | 1.80 ± 0.14 |
kcat (s−1) | 0.00031 ± 0.00001 | 0.00076 ± 0.00003 | 0.00015 ± 0.00001 | 0.0047 ± 0.0001 | 0.0039 ± 0.0002 | 0.0021 ± 0.0001 |
kcat/Km (M−1 s−1) UDP-linked sugar | 0.28 | 135 | 0.75 | 2.0 | 260 | 1.0 |
The B. pertussis enzyme was analyzed in a similar manner, using NAD+ concentrations of 15.0, 2.5, 1.0, and 0.4 mM and UDP-GlcNAcA concentrations of 23.6, 6.9, 2.0, and 0.75 mM. Kinetic parameters are presented in Table 3.
UDP-glucose, UDP-galactose, UDP-GlcNAc, and UDP-GlcA were screened as possible substrates for WlbA. Of the four, only UDP-GlcA was converted into a 3-keto sugar. Kinetic parameters were determined for both enzymes using UDP-GlcA as a substrate. The parameters for NAD+ were also measured again to ensure that UDP-GlcA did not perturb the binding of the dinucleotide. These parameters were determined via saturation kinetics and the data fitted to equation 2.
(2) |
The kinetic parameters are listed in Table 3.
We were also interested in determining if there was an enhancement in UDP-GlcNAcA binding or turnover in the presence of the next enzyme in the pathway, the aminotransferase WlbC, which converts the 3-keto sugar generated by WlbA into a 3-amino sugar (Scheme 1). Similar assay conditions were used with an excess of glutamate (30 mM), and varying the amount of WlbC until it was determined at what point it was not a limiting reagent in the assay. This occurred when the amount of WlbC was in at least a 2× molar excess over the amount of WlbA. Kinetic parameters were then determined by measuring the formation of NADH, starting with the original assay conditions, the addition of 30 mM glutamate, and a 2.5 molar excess of WlbC over WlbA. The NAD+ and UDP-GlcNAcA concentrations were varied as needed. Binding constants were determined using saturation kinetics and fitted to equation 2. These kinetic parameters are also presented in Table 3.
Results and Discussion
Functional Analysis of WlbA from B. pertussis and C. violaceum
In previous investigations, the P. aeruginosa WlbA was shown to employ a ping-pong catalytic mechanism and to use an NAD+ recycling pathway that couples WlbA and WlbC together (6, 7). As indicated in Scheme 1, WlbC is an aminotransferase that catalyses an amination step in the biosynthesis of UDP-ManNAc3NAcA. Assuming that the B. pertussis and C. violaceum dehydrogenases would function in a similar manner to that of the P. aeruginosa enzyme, we initially attempted to monitor UDP-3-keto-GlcNAcA formation via an HPLC assay as previously described (7). It was expected that an observable reaction yielding UDP-3-keto-GlcNAcA would result by mixing WlbA, UDP-GlcNAcA, WlbC, and glutamate. To our surprise, no reaction occurred. Similarly, no catalysis occurred if a reaction mixture of WlbA and UDP-GlcNAcA alone was spiked with α-ketoglutarate in the absence of the aminotransferase enzyme. In contrast, this same type of reaction mixture yielded UDP-3-keto-GlcNAcA in assays with the P. aeruginosa enzyme (6, 7). It was finally determined that the reaction required the addition of an equimolar ratio of NAD+ to UDP-GlcNAcA for both the B. pertussis and C. violaceum enzymes to catalyze the formation of UDP-3-keto-GlcNAcA.
Kinetic parameters were subsequently determined for both the B. pertussis and C. violaceum enzymes by monitoring spectrophotometrically the conversion of NAD+ to NADH. For both enzymes, double reciprocal plots clearly showed a series of intersecting lines indicative of a sequential mechanism (Figure 2). The activities of the B. pertussis and C. violaceum enzymes were also tested against UDP-glucose, UDP-galactose, UDP-GlcNAc, and UDP-GlcA. Neither enzyme could turnover UDP-glucose, UDP-galactose, or UDP-GlcNAc, but both were able to function on UDP-GlcA. Relevant kinetic parameters for the enzymes using UDP-GlcA as a substrate are given in Table 3. As discussed below, the carboxylate group attached to the C-5' carbon of the hexose in the natural substrate, UDP-GlcNAcA, is held firmly in place in the WlbA active site by the side chains of Arg 165 and Tyr 169. Most likely the absence of this carboxylate group, as in the case of UDP-glucose, UDP-galactose, or UDP-GlcNAc, results in either no binding or nonproductive binding to WlbA. The fact that WlbA can turnover UDP-GlcA also suggests that an N-acetyl group at the C-2' position of the hexose, as in UDP-GlcNAcA, is not important for proper substrate positioning. Indeed, as described below, the N-acetyl group of UDP-GlcNAcA, when bound in the enzyme active site, is simply surrounded by water molecules.
The catalytic efficiencies of the enzymes from C. violaceum and B. pertussis were determined to be 0.28 and 2.0 M−1s−1, respectively (Table 3). These values are significantly reduced from those measured for the T. thermophilus and P. aeruginosa enzymes (5.6 × 105 and 2.2 × 107 M−1s−1, respectively) (7). Given the low catalytic efficiencies for the C. violaceum and B. pertussis enzymes, the question was raised as to whether the genes encoding them were correctly annotated. Recent investigations by Westman et al., using complementation analyses of wlbA knockout mutants document that WlbA from B. pertussis functions in UDP-ManNAc3NAcA biosynthesis and that it catalyzes the reported oxidation reaction (4). Regardless of the low catalytic efficiencies measured in vitro, these enzymes clearly support function in vivo.
We were curious as to whether the addition of WlbC, the next enzyme in the biosynthetic pathway (Scheme 1), would have any effect on the kinetic parameters of the B. pertussis and C. violaceum enzymes. The catalytic efficiencies for both enzymes improved to 135 and 260 M−1s−1, respectively (Table 3). With respect to the C. violaceum enzyme, the Km for the UDP-linked sugar dropped from 1.10 to 0.0056 mM, whereas the Km for the NAD+ cofactor dropped from 0.47 to 0.089 mM. Likewise, the same trend occurred with the B. pertussis WlbA. Specifically the Km for the UDP-linked sugar was reduced from 2.36 to 0.015 mM, whereas the Km for the NAD+ cofactor was reduced from 0.97 to 0.055 mM. These data are highly suggestive of some type of protein:protein interaction occurring between WlbA and WlbC in vivo, and, indeed, this coupling phenomenon between the dehydrogenase and the aminotransferase has been previously reported for the P. aeruginosa enzyme (5, 6). Interestingly, if the reactions were conducted using UDP-GlcA as the substrate rather than UDP-GlcNAcA, the same enhancement of catalytic efficiency was not observed, and the kinetic parameters were essentially unchanged as listed in Table 3.
Structure of WlbA
Crystals of the B. pertussis WlbA belonged to the space group P21 with two octamers in the asymmetric unit. They diffracted to a nominal resolution of 2.13 Å. Overall the polypeptide chains corresponding to the sixteen subunits in the asymmetric unit were reasonably well ordered with only a few breaks in the electron densities. The Ramachandran statistics, as calculated according to PROCHECK (17), are good with 87.5, 12.2, and 0.3 % of the ϕ,ψ torsional angles lying within the core, allowed, and generously allowed regions.
Shown in Figure 3a is a ribbon representation of one of the octamers. It has overall dimensions of approximately 110 × 100 × 115 Å and displays 422 symmetry. It can be aptly described as a tetramer of dimers. A stereo-view of one of the dimers is shown in Figure 3b. The quaternary structure of the B. pertussis WlbA is completely different from that observed for WlbA from P. aeruginosa (Figure 1) even though the individual subunits have similar folds with one major exception as discussed below. In the B. pertussis enzyme, the active sites within the dimeric unit are positioned at greater than 40 Å apart and are contained within the individual subunits. This is in sharp contrast to the P. aeruginosa enzyme whereby the active sites are formed between subunits of the tetramer and lie closely to one another. The surface area buried per subunit upon formation of the B. pertussis octamer is approximately 3400 Å2. The C-terminal tails of each subunit project towards the interface of the octamer, and this is in keeping with the fact that placing a purification tag at the C-terminus of the B. pertussis WlbA always resulted in the expression of insoluble protein in E. coli.
The C. violaceum WlbA crystallized in the space group I422 with one subunit per asymmetric unit. Its quaternary structure is still octameric, however, as indicated by both crystalline packing considerations and analytical ultracentrifugation experiments. The overall folds of the C. violaceum and B. pertussis enzymes are similar such that their α-carbons superimpose with a root-mean-square deviation of 1.6 Å. Given their similarities in both amino acid sequences and three-dimensional structures, and the fact that the crystals of the C. violaceum WlbA diffracted to a higher resolution of 1.5 Å, the following discussion refers only to the C. violaceum enzyme unless otherwise indicated.
The model for the C. violaceum WlbA is excellent with 91.7% and 8.3% of the ϕ,ψ angles lying within the core and allowed regions of the Ramachandran plot, respectively. A close-up view of the single subunit in the asymmetric unit is presented in Figure 3c. Both Met 1 and the C-terminal Tyr 351 are visible in the electron density map. Three proline residues, at positions 105, 246, and 348, adopt cis conformations, and these cis prolines are conserved in the B. pertussis enzyme. Pro 105 is positioned near the nicotinamide ribose of the NAD(H) ligand, Pro 246 resides in a loop near the uracil group of the nucleotide-linked sugar, and Pro 348 sits close to the C-terminus, far removed from the active site cleft. Note that because the oxidation state of the dinucleotide is unknown, it will be referred to as NAD(H).
Overall the WlbA subunit can be described in terms of two domains: an N-terminal Rossmann fold defined by Met 1 to Lys 131 and a C-terminal region delineated by Gln 132 to Tyr 351. The N-terminal region, which provides the binding scaffold for the dinucleotide cofactor, is dominated by a decidedly twisted six stranded parallel β-sheet flanked on each side by three α-helices. The C-terminal domain, which harbors the binding site for UDP-GlcNAcA, consists of an eight-stranded mixed β-sheet surrounded by four α-helices on one side. The other side of the β-sheet provides the subunit:subunit interface of the “dimer” in the octamer (Figure 3b). As can be seen in Figure 3c, the C-terminal domain provides one of the α-helices flanking the β-sheet in the N-terminal Rossmann fold. There is only one break in the C. violaceum model between Ser 291 and Gly 298. In the B. pertussis enzyme, the structurally equivalent region adopts two turns of an α-helix and lies near the opening to the active site (Figure 3c).
The subunits for the WlbA enzymes from C. violaceum and P. aeruginosa superimpose with a root-mean-square deviation of 1.7 Å for 257 structurally equivalent α-carbons. Why are their quaternary structures so different? A superposition of their polypeptide chains, as presented in Figure 4, provides the answer. The N-terminus of the C. violaceum enzyme is longer by ten residues. This extended N-terminal tail projects towards the adenine ring of the NAD(H) in a fourfold-related monomer of the octamer. There is also an eight-residue insertion in the C. violaceum WlbA between Thr 213 and Asp 222, which projects towards another monomer of the octamer (labeled “loop” in Figure 4). The biggest differences in the two proteins occur at Tyr 245 (C. violaceum WlbA numbering) and at their C-termini. These areas are labeled Regions 1 and 2, respectively, in Figure 4. In the P. aeruginosa WlbA, there is a ten-residue insertion that adopts a helical conformation and abuts the large mixed β-sheet of the C-terminal domain. Likewise, the C-terminal residues in the P. aeruginosa WlbA lie against this β-sheet, whereas in the C. violaceum WlbA, they curl away to form another β-strand (Figure 4). Taken together, these two regions in the P. aeruginosa WlbA preclude it from forming a subunit:subunit interface that involves the large mixed β-sheet of the C-terminal domain.
Electron densities corresponding to the bound NAD(H) and UDP-GlcNAcA ligands are displayed in Figure 5a. The nucleotide-linked sugar adopts an extended conformation which is in stark contrast to that observed for the P. aeruginosa WlbA where the C-5 carbon of the uracil ring and the C-6' carbon of the hexose reside within 3.7 Å of each other. The carboxamide group of the NAD(H) is twisted out of the plane of the ring.
A close-up view of the NAD(H) binding pocket is presented in Figure 5b. Both riboses of the dinucleotide adopt the C2'-endo pucker. The adenine ring projects outwards towards the solvent and is surrounded by three water molecules. The adenine ribose is hydrogen bonded to the carboxylate of Asp 44 and one water molecule. Both Trp 175 and Arg 176 provide hydrogen-bonding interactions with the phosphoryl groups of the cofactor. Three waters and the backbone amides of Arg 21 and Ile 22 provide additional interactions with the phosphoryl groups. The nicotinamide/ribose portion of the cofactor is positioned into the active site via one water molecule, the side chains of Ser 83, His 86, Glu 103, and Gln 132, and the backbone carbonyls of Thr 81 and Lys 104.
Shown in Figure 5c is a close-up view of the UDP-GlcNAcA binding site. As in the case of the adenine ring in NAD(H), the uracil group is located towards the solvent. It is surrounded by two water molecules, and lies within hydrogen bonding distance of the backbone amide group of Asn 248. Only one well-ordered water molecule is situated within 3.2 Å of the phosphoryl groups of the UDP-linked sugar substrate. The N-acetyl group at position C-2' is surrounded by two water molecules. The C-3' hydroxyl, which is ultimately oxidized to a keto group, lies at 3.0 Å from the ε-nitrogen of Lys 104. Most likely Lys 104 serves as the catalytic base to abstract the proton from the C-3' hydroxyl group. The side chain of Lys 104 also lies within 3.0 Å of the C-4' hydroxyl, which is further surrounded by the side chain of Asn 188 and a water molecule. Note that Lys 104 is conserved in the P. aeruginosa and T. thermophilus enzymes as well. Finally, the C-5' carboxylate group of the hexose is anchored to the protein through interactions with the side chains of Arg 165 and Tyr 169 and two water molecules. The hexose C-3' carbon atom, which loses a hydride to NAD+ during catalysis, faces the re face of the nicotinamide ring of the cofactor and sits at 4.0 Å from the cofactor C-4 carbon. The mode of NAD(H) and UDP-GlcNAcA binding to the C. violaceum WlbA is nearly identical to that observed for the B. pertussis enzyme except that in the latter protein, Arg 20 projects into the active site where it forms electrostatic interactions with the phosphoryl groups of UDP-GlcNAcA.
As noted above, the B. pertussis and C. violaceum WlbA enzymes do not undergo the cofactor recycling mechanism observed for the P. aeruginosa enzyme. A close-up view of the binding pocket for α-ketoglutarate, as observed in the P. aeruginosa WlbA, is shown in Figure 6. Key residues involved in binding α-ketoglutarate include Lys 101, Tyr 156, Thr 158, Arg 160, His 185, and Arg 245. Three of these residues, Lys 101, His 185, and Arg 160 are retained as Lys 104, His 192, and Arg 165 in the C. violaceum enzyme (Figure 6). Tyr 156, Thr 158, and Arg 245, which form electrostatic interactions with the side chain carboxylate of α-ketoglutarate in the P. aeruginosa WlbA active site, are replaced with Val 161, Trp 163, and Gly 251, respectively, in the C. violaceum active site. These changes in amino acid residues preclude the binding of α-ketoglutarate into the active site of the C. violaceum WlbA.
In summary, the results presented here demonstrate that there are two families of WlbA enzymes involved in the biosynthesis of UDP-ManNAc3NAcA, which we will refer to as Class A and Class B. With respect to primary structure, family members can be distinguished on the basis of their amino acid sequences. Within the Class A or Class B families, members typically demonstrate greater than 45% amino acid sequence identity. Between classes, however, the amino acid sequence identity is less than 15%. The Class A members, defined by the P. aeruginosa WlbA, adopt unusual tetrameric structures with their active sites positioned between subunits and their nucleotide-linked sugars adopting highly curved conformations. Additionally, these enzymes employ α-ketoglutarate in their NAD+ recycling systems, at least in vitro, and they display ping-pong reaction mechanisms. Contrastingly, members of the Class B family, defined by the B. pertussis WlbA, function as octamers, display sequential reaction kinetics, and cannot accommodate α-ketoglutarate in their active sites. These differences in the structures and mechanisms of the two WlbA families have important ramifications for the potential design of new therapeutics in the treatment of P. aeruginosa and B. pertussis infections.
Acknowledgments
A portion of the research described in this paper was performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source (United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357). We gratefully acknowledge Dr. Norma E. C. Duke for assistance during the X-ray data collection at Argonne and Professor W. W. Cleland for helpful discussions.
Footnotes
This research was supported in part by an NIH grant (DK47814 to H. M. H.).
X-ray coordinates have been deposited in the Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, N. J., (accession nos. 3Q2I and 3Q2K).
Abbreviations: HEPPS, 3-[4-(2-hydroxyethyl)-1-piperazinyl]propanesulfonic acid; HPLC, high-performance liquid chromatography; IPTG, isopropyl-β-d-thiogalactopyranoside; LB, Luria-Bertani; NAD(H), nicotinamide adenine dinucleotide; NiNTA, nickel-nitrilotriacetic acid; PCR, polymerase chain reaction; TEV, tobacco etch virus; Tris, 2-amino-2-hydroxymethyl-propane-1,3-diol; UDP, uridine 5'-phosphate; UDP-GlcA, UDP-d-glucuronic acid; UDP-GlcNAc, UDP-N-acetyl-d-glucosamine; UDP-GlcNAcA, UDP-N-acetyl-d-glucosaminuronic acid; UDP-3-keto-GlcNAcA, UDP-2-acetamido-2-deoxy-3-oxo-d-glucuronic acid; UDP-GlcNAc3NA, UDP-2-acetamido-3-amino-2,3-dideoxy-d-glucuronic acid; UDP-GlcNAc3NAcA, UDP-2,3-diacetamido-2,3-dideoxy-d-glucuronic acid; UDP-ManNAc3NAcA, UDP-2,3-diacetamido-2,3-dideoxy-d-mannuronic acid.
References
- 1.Knirel YA, Kochetkov NK. Structure of lipopolysaccharides from Gram-negative bacteria. III. Structure of O-specific polysaccharides. Biokhimiia. 1994;59:1784–1851. [PubMed] [Google Scholar]
- 2.Harvill ET, Preston A, Cotter PA, Allen AG, Maskell DJ, Miller JF. Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun. 2000;68:6720–6728. doi: 10.1128/iai.68.12.6720-6728.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Schaeffer LM, McCormack FX, Wu H, Weiss AA. Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol. 2004;173:1959–1965. doi: 10.4049/jimmunol.173.3.1959. [DOI] [PubMed] [Google Scholar]
- 4.Westman EL, Preston A, Field RA, Lam JS. Biosynthesis of a rare di-N-acetylated sugar in the lipopolysaccharides of both Pseudomonas aeruginosa and Bordetella pertussis occurs via an identical scheme despite different gene clusters. J Bacteriol. 2008;190:6060–6069. doi: 10.1128/JB.00579-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Westman EL, McNally DJ, Charchoglyan A, Brewer D, Field RA, Lam JS. Characterization of WbpB, WbpE, and WbpD and reconstitution of a pathway for the biosynthesis of UDP-2,3-diacetamido-2,3-dideoxy-d-mannuronic acid in Pseudomonas aeruginosa. J Biol Chem. 2009;284:11854–11862. doi: 10.1074/jbc.M808583200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Larkin A, Imperiali B. Biosynthesis of UDP-GlcNAc(3NAc)A by WbpB, WbpE, and WbpD: enzymes in the Wbp pathway responsible for O-antigen assembly in Pseudomonas aeruginosa PAO1. Biochemistry. 2009;48:5446–5455. doi: 10.1021/bi900186u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Thoden JB, Holden HM. Structural and functional studies of WlbA: A dehydrogenase involved in the biosynthesis of 2,3-diacetamido-2,3-dideoxy-D-mannuronic acid. Biochemistry. 2010;49:7939–7948. doi: 10.1021/bi101103s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kingston RL, Scopes RK, Baker EN. The structure of glucose-fructose oxidoreductase from Zymomonas mobilis: an osmoprotective periplasmic enzyme containing non-dissociable NADP. Structure. 1996;4:1413–1428. doi: 10.1016/s0969-2126(96)00149-9. [DOI] [PubMed] [Google Scholar]
- 9.Lichstein HC, Van De Sand VF. The antibiotic activity of violacein, prodigiosin, and phthiocol. J Bacteriol. 1946;52:145–146. [PMC free article] [PubMed] [Google Scholar]
- 10.Thoden JB, Timson DJ, Reece RJ, Holden HM. Molecular structure of human galactokinase: implications for Type II galactosemia. J Biol Chem. 2005;280:9662–9670. doi: 10.1074/jbc.M412916200. [DOI] [PubMed] [Google Scholar]
- 11.Minor W, Cymborowski M, Otwinowski Z, Chruszcz M. HKL-3000: the integration of data reduction and structure solution-from diffraction images to an initial model in minutes. Acta Crystallogr D Biol Crystallogr. 2006;62:859–866. doi: 10.1107/S0907444906019949. [DOI] [PubMed] [Google Scholar]
- 12.Terwilliger TC, Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr D Biol Crystallogr. 1999;55(Pt 4):849–861. doi: 10.1107/S0907444999000839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- 14.McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J. Appl. Cryst. 2007;40:658–674. doi: 10.1107/S0021889807021206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr. 1997;53:240–255. doi: 10.1107/S0907444996012255. [DOI] [PubMed] [Google Scholar]
- 16.Cowtan K. 'DM:' An automated procedure for phase improvement by density modification. Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography. 1994;31:34–38. [Google Scholar]
- 17.Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 1993;26:283–291. [Google Scholar]
- 18.DeLano WL. The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA, USA. San Carlos, CA, USA: The PyMOL Molecular Graphics System. DeLano Scientific; 2002. [Google Scholar]